Hims & Hers Shareholders Elect Nine Directors and Approve All Proposals at Annual Meeting

Hims & Hers Health, Inc. announced the voting results from its 2026 Annual Meeting of Stockholders held on June 11, 2026. All three proposals presented to shareholders were approved by a significant majority.

Key Details

• Director Elections: All nine director nominees, including CEO Andrew Dudum, were elected to the board to serve until the 2027 annual meeting.
• Auditor Ratification: Shareholders ratified the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
• Executive Compensation: The company's executive compensation plan was approved on a non-binding, advisory basis.